EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted. Green numbers along left margin indicate location on the printed bill (e.g., 5-15 indicates page 5, line 15).

1-1 Whereas, Chronic fatigue syndrome is an illness characterized by

1-2 prolonged, debilitating fatigue and multiple nonspecific symptoms such as

1-3 headaches, muscle and joint pains, sleep disturbances, recurrent sore

1-4 throats and cognitive impairment; and

1-5 Whereas, This illness is often misdiagnosed and its cause erroneously

1-6 attributed to conditions irrelevant to the disorder; and

1-7 Whereas, Because the cause of this disorder is unknown and there are

1-8 no diagnostic tests, this disorder is diagnosed when the symptoms persist

1-9 for more than 6 months and cannot be attributed to any other medical

1-10 condition; and

1-11 Whereas, Recent studies have indicated that chronic fatigue syndrome

1-12 is a far greater public health problem than previously known, affecting

1-13 men and women of all racial and ethnic groups, as well as adolescents,

1-14 with the highest prevalence occurring among Caucasian women; and

1-15 Whereas, Many patients with chronic fatigue syndrome are unable to

1-16 continue holding jobs, attending school or caring for family members; and

1-17 Whereas, Treatment of chronic fatigue syndrome is currently focused

1-18 on symptomatic relief since there is no single drug or group of drugs

1-19 specific to this disease; and

2-1 Whereas, Extensive scientific research is needed to determine the

2-2 cause and cure for chronic fatigue syndrome, such as the recent

2-3 double-blind, placebo-controlled, crossover pilot study conducted at

2-4 Georgetown University Medical Center resulting in the discovery that a

2-5 naturally occurring coenzyme, commercially available as ENADAâ , can

2-6 alleviate symptoms of this debilitating disorder; and

2-7 Whereas, Nevada’s own Dr. Daniel L. Peterson, who is a member of

2-8 the Sierra Internal Medicine Associates in Incline Village, Nevada, is well

2-9 known for his role in the fight against chronic fatigue syndrome; and

2-10 Whereas, Since 1984, Dr. Peterson has treated more than 2,000

2-11 patients with chronic fatigue syndrome; and

2-12 Whereas, Dr. Peterson’s dedication to this cause is evidenced by his

2-13 tenure as Medical Director of the Fatigue Clinic for the diagnosis of

2-14 fatigue and the treatment of chronic fatigue and immune dysfunction

2-15 syndrome at the Neurology Clinic of the University of California, San

2-16 Francisco; and

2-17 Whereas, Dr. Peterson is a member of the International Chronic

2-18 Fatigue Syndrome Study Group, and has earned nationwide recognition as

2-19 co-author of many articles relating to chronic fatigue syndrome which have

2-20 appeared in medical journals and publications throughout the country; and

2-21 Whereas, In treating patients with chronic fatigue syndrome, Dr.

2-22 Peterson has drawn on practices that have made medicine a valued art by

2-23 excluding alternative problems, ameliorating symptoms and offering

2-24 guidance with compassion; now, therefore, be it

2-25 Resolved by the Assembly and Senate of the State of Nevada,

2-26 Jointly, That the members of the 70th session of the Nevada Legislature

2-27 do hereby commend Dr. Peterson for his outstanding work and selfless

2-28 dedication on behalf of persons with chronic fatigue syndrome; and be it

2-29 further

2-30 Resolved, That the Nevada Legislature hereby urges Congress to

2-31 provide financial support and ensure that federal health agencies allocate

2-32 increasing resources for additional scientific research to combat chronic

2-33 fatigue syndrome; and be it further

2-34 Resolved, That the Chief Clerk of the Assembly prepare and transmit

2-35 a copy of this resolution to Dr. Daniel L. Peterson and to the Vice

2-36 President of the United States as the presiding officer of the Senate, the

2-37 Speaker of the House of Representatives and each member of the Nevada

2-38 Congressional Delegation; and be it further

2-39 Resolved, That this resolution becomes effective upon passage and

2-40 approval.